Skip to main content
. 2023 Jul 4;8(4):101592. doi: 10.1016/j.esmoop.2023.101592

Figure 4.

Figure 4

Hazard ratio (HR) for overall survival of HER2-low breast cancers versus HER2-zero breast cancers in the overall population in the early setting (the size of the squares is proportional to the weight of each study).

CI, confidence interval; HER2, human epidermal growth factor receptor 2. Random effect: P < 0.001; Egger’s test: P = 0.031.